These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23037475)

  • 21. Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma.
    Mohammed Saleh MF; Kotb A; Abdallah GEM; Muhsen IN; El Fakih R; Aljurf M
    Curr Oncol; 2021 Dec; 28(6):5480-5498. PubMed ID: 34940095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.
    Awaya N; Adachi A; Mori T; Kamata H; Nakahara J; Yokoyama K; Yamada T; Kizaki M; Sakamoto M; Ikeda Y; Okamoto S
    Leuk Res; 2006 Aug; 30(8):1059-62. PubMed ID: 16330097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning.
    Oji Y; Oka Y; Tatekawa T; Soma T; Matsunashi T; Yamagami T; Tsuboi A; Tamaki H; Kim EH; Sugiyama H; Ogawa H
    Int J Hematol; 1999 Jun; 69(4):263-7. PubMed ID: 10407585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review.
    Elliott MA; Nichols WL; Plumhoff EA; Ansell SM; Dispenzieri A; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Micallef IN; Tefferi A; Litzow M
    Mayo Clin Proc; 2003 Apr; 78(4):421-30. PubMed ID: 12683694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Esophageal actinomycosis after allogeneic peripheral blood stem cell transplantation for extranodal natural killer/T cell lymphoma, nasal type.
    Yagi T; Fujino H; Hirai M; Inoue T; Sako M; Teshima H; Fujii S; Hino M
    Bone Marrow Transplant; 2003 Aug; 32(4):451-3. PubMed ID: 12900786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The first 2 years of clinical experience with peripheral blood stem cell transplantation for various hematological malignancies: results from a single Baskent University Center.
    Ozdogu H; Boga C; Kizilkilic E; Kozanoglu I; Karakus S; Sahin FI; Unalan D; Haberal M
    Transplant Proc; 2007 May; 39(4):1257-60. PubMed ID: 17524948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas.
    Castagna L; Bertuzzi A; Nozza A; Siracusano L; Balzarotti M; Magagnoli M; Sarina B; Timofeeva I; Sinnone M; Grimoldi MG; Farè M; Santoro A
    Bone Marrow Transplant; 2002 Aug; 30(4):207-14. PubMed ID: 12203136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemophagocytic Lymphohistiocytosis in Cutaneous T-Cell Lymphoma.
    Lee DE; Martinez-Escala ME; Serrano LM; Zhou XA; Kaplan JB; Pro B; Choi J; Guitart J
    JAMA Dermatol; 2018 Jul; 154(7):828-831. PubMed ID: 29874360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced-intensity conditioning and blood stem cell transplantation from an HLA-identical sibling for severe aplastic anaemia: two patients with successful engraftment but a fatal post-transplant lymphoproliferative disorder in the other.
    Itälä M; Aho H; Remes K
    Hematol J; 2004; 5(5):440-3. PubMed ID: 15448671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients.
    Caballero-Velázquez T; López-Corral L; Encinas C; Castilla-Llorente C; Martino R; Rosiñol L; Sampol A; Caballero D; Serrano D; Heras I; San Miguel J; Pérez-Simón JA
    Br J Haematol; 2013 Aug; 162(4):474-82. PubMed ID: 23772672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma.
    Wulf GG; Hasenkamp J; Jung W; Chapuy B; Truemper L; Glass B
    Bone Marrow Transplant; 2005 Aug; 36(3):271-3. PubMed ID: 15937499
    [No Abstract]   [Full Text] [Related]  

  • 33. Allogeneic transplantation in T-cell lymphomas.
    Schmitz N; Wu HS; Glass B
    Semin Hematol; 2014 Jan; 51(1):67-72. PubMed ID: 24468318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma.
    Tapprich C; Fenk R; Schneider P; Bernhardt A; Haas R; Kobbe G
    Bone Marrow Transplant; 2003 Sep; 32(6):629-31. PubMed ID: 12953137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of chemotherapy-refractory angioimmunoblastic T cell lymphoma with cyclosporin A.
    Kobayashi T; Kuroda J; Uchiyama H; Matsumoto Y; Horiike S; Taniwaki M
    Acta Haematol; 2012; 127(1):10-5. PubMed ID: 21986307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Case of Refractory Langerhans Cell Histiocytosis Complicated with Hemophagocytic Lymphohistiocytosis Rescued by Cord Blood Transplantation with Reduced-intensity Conditioning.
    Washio K; Muraoka M; Kanamitsu K; Oda M; Shimada A
    Acta Med Okayama; 2017 Jun; 71(3):249-254. PubMed ID: 28655945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epstein-Barr virus-related B-cell lymphoma of the skin which developed early after cord blood transplantation for angioimmunoblastic T-cell lymphoma].
    Tajika K; Tamai H; Mizuki T; Nakayama K; Yamaguchi H; Dan K
    Rinsho Ketsueki; 2010 Feb; 51(2):138-42. PubMed ID: 20379106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategies.
    Alizadeh AA; Advani RH
    Clin Adv Hematol Oncol; 2008 Dec; 6(12):899-909. PubMed ID: 19209140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
    Kuroki F; Goto H; Yanagimachi M; Kajiwara R; Fujii H; Isaki S; Takahashi H; Ikuta K; Yokota S
    Rinsho Ketsueki; 2006 Jul; 47(7):639-44. PubMed ID: 16910574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful rituximab treatment of an EBV-related lymphoproliferative disease arising after autologous transplantation for angioimmunoblastic T-cell lymphoma.
    Park S; Noguera ME; Brière J; Feuillard J; Cayuela JM; Sigaux F; Brice P
    Hematol J; 2002; 3(6):317-20. PubMed ID: 12522456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.